Sequana Medical Announces the Completion of alfapump Implantations in POSEIDON, the North American Pivotal alfapump Study
Sequana MedicalFigure 1Kaplan Meier – Preliminary survival rate analysis of Roll-In Cohort, dated 25 March 2022Reporting of primary endpoint on...
